The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Covid-19 Rapid Antigen Market Research Report 2025
Synopsis
The global Covid-19 Rapid Antigen market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Covid-19 Rapid Antigen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Covid-19 Rapid Antigen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Covid-19 Rapid Antigen include Abbott, Access Bio, BD, Quidel, Fujirebio, Ellume, OraSure Technologies, Clip Health and Celltrion Healthcare, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Covid-19 Rapid Antigen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Covid-19 Rapid Antigen.
Report Scope
The Covid-19 Rapid Antigen market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Covid-19 Rapid Antigen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Covid-19 Rapid Antigen manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Access Bio
BD
Quidel
Fujirebio
Ellume
OraSure Technologies
Clip Health
Celltrion Healthcare
Salofa Oy
iHealth Labs
Novegent
Hangzhou Alltest Biotech
Guangzhou Decheng Biotechnology
SD Biosensor
MP Biomedical
Jiangsu Well Biotech
CTK Biotech
Hangzhou Laihe Biotech
Innovation Scientific
Biohit Healthcare
ACON Biotech
Assure Tech
Hangzhou Clongene Biotech
Hangzhou Testsea Biotechnology
Segment by Type
Nasal Swab
Oral Fluid/Saliva
Segment by Application
Hospitals
Scientific Research
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Covid-19 Rapid Antigen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Covid-19 Rapid Antigen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Covid-19 Rapid Antigen market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Covid-19 Rapid Antigen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Covid-19 Rapid Antigen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Covid-19 Rapid Antigen include Abbott, Access Bio, BD, Quidel, Fujirebio, Ellume, OraSure Technologies, Clip Health and Celltrion Healthcare, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Covid-19 Rapid Antigen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Covid-19 Rapid Antigen.
Report Scope
The Covid-19 Rapid Antigen market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Covid-19 Rapid Antigen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Covid-19 Rapid Antigen manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Access Bio
BD
Quidel
Fujirebio
Ellume
OraSure Technologies
Clip Health
Celltrion Healthcare
Salofa Oy
iHealth Labs
Novegent
Hangzhou Alltest Biotech
Guangzhou Decheng Biotechnology
SD Biosensor
MP Biomedical
Jiangsu Well Biotech
CTK Biotech
Hangzhou Laihe Biotech
Innovation Scientific
Biohit Healthcare
ACON Biotech
Assure Tech
Hangzhou Clongene Biotech
Hangzhou Testsea Biotechnology
Segment by Type
Nasal Swab
Oral Fluid/Saliva
Segment by Application
Hospitals
Scientific Research
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Covid-19 Rapid Antigen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Covid-19 Rapid Antigen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Covid-19 Rapid Antigen Market Overview
1.1 Product Overview and Scope of Covid-19 Rapid Antigen
1.2 Covid-19 Rapid Antigen Segment by Type
1.2.1 Global Covid-19 Rapid Antigen Market Value Comparison by Type (2024-2030)
1.2.2 Nasal Swab
1.2.3 Oral Fluid/Saliva
1.3 Covid-19 Rapid Antigen Segment by Application
1.3.1 Global Covid-19 Rapid Antigen Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Scientific Research
1.4 Global Covid-19 Rapid Antigen Market Size Estimates and Forecasts
1.4.1 Global Covid-19 Rapid Antigen Revenue 2019-2030
1.4.2 Global Covid-19 Rapid Antigen Sales 2019-2030
1.4.3 Global Covid-19 Rapid Antigen Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Covid-19 Rapid Antigen Market Competition by Manufacturers
2.1 Global Covid-19 Rapid Antigen Sales Market Share by Manufacturers (2019-2024)
2.2 Global Covid-19 Rapid Antigen Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Covid-19 Rapid Antigen Average Price by Manufacturers (2019-2024)
2.4 Global Covid-19 Rapid Antigen Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Covid-19 Rapid Antigen, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Covid-19 Rapid Antigen, Product Type & Application
2.7 Covid-19 Rapid Antigen Market Competitive Situation and Trends
2.7.1 Covid-19 Rapid Antigen Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Covid-19 Rapid Antigen Players Market Share by Revenue
2.7.3 Global Covid-19 Rapid Antigen Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Covid-19 Rapid Antigen Retrospective Market Scenario by Region
3.1 Global Covid-19 Rapid Antigen Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Covid-19 Rapid Antigen Global Covid-19 Rapid Antigen Sales by Region: 2019-2030
3.2.1 Global Covid-19 Rapid Antigen Sales by Region: 2019-2024
3.2.2 Global Covid-19 Rapid Antigen Sales by Region: 2025-2030
3.3 Global Covid-19 Rapid Antigen Global Covid-19 Rapid Antigen Revenue by Region: 2019-2030
3.3.1 Global Covid-19 Rapid Antigen Revenue by Region: 2019-2024
3.3.2 Global Covid-19 Rapid Antigen Revenue by Region: 2025-2030
3.4 North America Covid-19 Rapid Antigen Market Facts & Figures by Country
3.4.1 North America Covid-19 Rapid Antigen Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Covid-19 Rapid Antigen Sales by Country (2019-2030)
3.4.3 North America Covid-19 Rapid Antigen Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Covid-19 Rapid Antigen Market Facts & Figures by Country
3.5.1 Europe Covid-19 Rapid Antigen Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Covid-19 Rapid Antigen Sales by Country (2019-2030)
3.5.3 Europe Covid-19 Rapid Antigen Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Covid-19 Rapid Antigen Market Facts & Figures by Country
3.6.1 Asia Pacific Covid-19 Rapid Antigen Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Covid-19 Rapid Antigen Sales by Country (2019-2030)
3.6.3 Asia Pacific Covid-19 Rapid Antigen Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Covid-19 Rapid Antigen Market Facts & Figures by Country
3.7.1 Latin America Covid-19 Rapid Antigen Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Covid-19 Rapid Antigen Sales by Country (2019-2030)
3.7.3 Latin America Covid-19 Rapid Antigen Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Covid-19 Rapid Antigen Market Facts & Figures by Country
3.8.1 Middle East and Africa Covid-19 Rapid Antigen Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Covid-19 Rapid Antigen Sales by Country (2019-2030)
3.8.3 Middle East and Africa Covid-19 Rapid Antigen Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Covid-19 Rapid Antigen Sales by Type (2019-2030)
4.1.1 Global Covid-19 Rapid Antigen Sales by Type (2019-2024)
4.1.2 Global Covid-19 Rapid Antigen Sales by Type (2025-2030)
4.1.3 Global Covid-19 Rapid Antigen Sales Market Share by Type (2019-2030)
4.2 Global Covid-19 Rapid Antigen Revenue by Type (2019-2030)
4.2.1 Global Covid-19 Rapid Antigen Revenue by Type (2019-2024)
4.2.2 Global Covid-19 Rapid Antigen Revenue by Type (2025-2030)
4.2.3 Global Covid-19 Rapid Antigen Revenue Market Share by Type (2019-2030)
4.3 Global Covid-19 Rapid Antigen Price by Type (2019-2030)
5 Segment by Application
5.1 Global Covid-19 Rapid Antigen Sales by Application (2019-2030)
5.1.1 Global Covid-19 Rapid Antigen Sales by Application (2019-2024)
5.1.2 Global Covid-19 Rapid Antigen Sales by Application (2025-2030)
5.1.3 Global Covid-19 Rapid Antigen Sales Market Share by Application (2019-2030)
5.2 Global Covid-19 Rapid Antigen Revenue by Application (2019-2030)
5.2.1 Global Covid-19 Rapid Antigen Revenue by Application (2019-2024)
5.2.2 Global Covid-19 Rapid Antigen Revenue by Application (2025-2030)
5.2.3 Global Covid-19 Rapid Antigen Revenue Market Share by Application (2019-2030)
5.3 Global Covid-19 Rapid Antigen Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Covid-19 Rapid Antigen Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Access Bio
6.2.1 Access Bio Corporation Information
6.2.2 Access Bio Description and Business Overview
6.2.3 Access Bio Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Access Bio Covid-19 Rapid Antigen Product Portfolio
6.2.5 Access Bio Recent Developments/Updates
6.3 BD
6.3.1 BD Corporation Information
6.3.2 BD Description and Business Overview
6.3.3 BD Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BD Covid-19 Rapid Antigen Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 Quidel
6.4.1 Quidel Corporation Information
6.4.2 Quidel Description and Business Overview
6.4.3 Quidel Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Quidel Covid-19 Rapid Antigen Product Portfolio
6.4.5 Quidel Recent Developments/Updates
6.5 Fujirebio
6.5.1 Fujirebio Corporation Information
6.5.2 Fujirebio Description and Business Overview
6.5.3 Fujirebio Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Fujirebio Covid-19 Rapid Antigen Product Portfolio
6.5.5 Fujirebio Recent Developments/Updates
6.6 Ellume
6.6.1 Ellume Corporation Information
6.6.2 Ellume Description and Business Overview
6.6.3 Ellume Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ellume Covid-19 Rapid Antigen Product Portfolio
6.6.5 Ellume Recent Developments/Updates
6.7 OraSure Technologies
6.6.1 OraSure Technologies Corporation Information
6.6.2 OraSure Technologies Description and Business Overview
6.6.3 OraSure Technologies Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.4.4 OraSure Technologies Covid-19 Rapid Antigen Product Portfolio
6.7.5 OraSure Technologies Recent Developments/Updates
6.8 Clip Health
6.8.1 Clip Health Corporation Information
6.8.2 Clip Health Description and Business Overview
6.8.3 Clip Health Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Clip Health Covid-19 Rapid Antigen Product Portfolio
6.8.5 Clip Health Recent Developments/Updates
6.9 Celltrion Healthcare
6.9.1 Celltrion Healthcare Corporation Information
6.9.2 Celltrion Healthcare Description and Business Overview
6.9.3 Celltrion Healthcare Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Celltrion Healthcare Covid-19 Rapid Antigen Product Portfolio
6.9.5 Celltrion Healthcare Recent Developments/Updates
6.10 Salofa Oy
6.10.1 Salofa Oy Corporation Information
6.10.2 Salofa Oy Description and Business Overview
6.10.3 Salofa Oy Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Salofa Oy Covid-19 Rapid Antigen Product Portfolio
6.10.5 Salofa Oy Recent Developments/Updates
6.11 iHealth Labs
6.11.1 iHealth Labs Corporation Information
6.11.2 iHealth Labs Covid-19 Rapid Antigen Description and Business Overview
6.11.3 iHealth Labs Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.11.4 iHealth Labs Covid-19 Rapid Antigen Product Portfolio
6.11.5 iHealth Labs Recent Developments/Updates
6.12 Novegent
6.12.1 Novegent Corporation Information
6.12.2 Novegent Covid-19 Rapid Antigen Description and Business Overview
6.12.3 Novegent Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Novegent Covid-19 Rapid Antigen Product Portfolio
6.12.5 Novegent Recent Developments/Updates
6.13 Hangzhou Alltest Biotech
6.13.1 Hangzhou Alltest Biotech Corporation Information
6.13.2 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Description and Business Overview
6.13.3 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product Portfolio
6.13.5 Hangzhou Alltest Biotech Recent Developments/Updates
6.14 Guangzhou Decheng Biotechnology
6.14.1 Guangzhou Decheng Biotechnology Corporation Information
6.14.2 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Description and Business Overview
6.14.3 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product Portfolio
6.14.5 Guangzhou Decheng Biotechnology Recent Developments/Updates
6.15 SD Biosensor
6.15.1 SD Biosensor Corporation Information
6.15.2 SD Biosensor Covid-19 Rapid Antigen Description and Business Overview
6.15.3 SD Biosensor Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.15.4 SD Biosensor Covid-19 Rapid Antigen Product Portfolio
6.15.5 SD Biosensor Recent Developments/Updates
6.16 MP Biomedical
6.16.1 MP Biomedical Corporation Information
6.16.2 MP Biomedical Covid-19 Rapid Antigen Description and Business Overview
6.16.3 MP Biomedical Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.16.4 MP Biomedical Covid-19 Rapid Antigen Product Portfolio
6.16.5 MP Biomedical Recent Developments/Updates
6.17 Jiangsu Well Biotech
6.17.1 Jiangsu Well Biotech Corporation Information
6.17.2 Jiangsu Well Biotech Covid-19 Rapid Antigen Description and Business Overview
6.17.3 Jiangsu Well Biotech Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Jiangsu Well Biotech Covid-19 Rapid Antigen Product Portfolio
6.17.5 Jiangsu Well Biotech Recent Developments/Updates
6.18 CTK Biotech
6.18.1 CTK Biotech Corporation Information
6.18.2 CTK Biotech Covid-19 Rapid Antigen Description and Business Overview
6.18.3 CTK Biotech Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.18.4 CTK Biotech Covid-19 Rapid Antigen Product Portfolio
6.18.5 CTK Biotech Recent Developments/Updates
6.19 Hangzhou Laihe Biotech
6.19.1 Hangzhou Laihe Biotech Corporation Information
6.19.2 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Description and Business Overview
6.19.3 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product Portfolio
6.19.5 Hangzhou Laihe Biotech Recent Developments/Updates
6.20 Innovation Scientific
6.20.1 Innovation Scientific Corporation Information
6.20.2 Innovation Scientific Covid-19 Rapid Antigen Description and Business Overview
6.20.3 Innovation Scientific Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Innovation Scientific Covid-19 Rapid Antigen Product Portfolio
6.20.5 Innovation Scientific Recent Developments/Updates
6.21 Biohit Healthcare
6.21.1 Biohit Healthcare Corporation Information
6.21.2 Biohit Healthcare Covid-19 Rapid Antigen Description and Business Overview
6.21.3 Biohit Healthcare Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Biohit Healthcare Covid-19 Rapid Antigen Product Portfolio
6.21.5 Biohit Healthcare Recent Developments/Updates
6.22 ACON Biotech
6.22.1 ACON Biotech Corporation Information
6.22.2 ACON Biotech Covid-19 Rapid Antigen Description and Business Overview
6.22.3 ACON Biotech Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.22.4 ACON Biotech Covid-19 Rapid Antigen Product Portfolio
6.22.5 ACON Biotech Recent Developments/Updates
6.23 Assure Tech
6.23.1 Assure Tech Corporation Information
6.23.2 Assure Tech Covid-19 Rapid Antigen Description and Business Overview
6.23.3 Assure Tech Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Assure Tech Covid-19 Rapid Antigen Product Portfolio
6.23.5 Assure Tech Recent Developments/Updates
6.24 Hangzhou Clongene Biotech
6.24.1 Hangzhou Clongene Biotech Corporation Information
6.24.2 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Description and Business Overview
6.24.3 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product Portfolio
6.24.5 Hangzhou Clongene Biotech Recent Developments/Updates
6.25 Hangzhou Testsea Biotechnology
6.25.1 Hangzhou Testsea Biotechnology Corporation Information
6.25.2 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Description and Business Overview
6.25.3 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product Portfolio
6.25.5 Hangzhou Testsea Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Covid-19 Rapid Antigen Industry Chain Analysis
7.2 Covid-19 Rapid Antigen Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Covid-19 Rapid Antigen Production Mode & Process
7.4 Covid-19 Rapid Antigen Sales and Marketing
7.4.1 Covid-19 Rapid Antigen Sales Channels
7.4.2 Covid-19 Rapid Antigen Distributors
7.5 Covid-19 Rapid Antigen Customers
8 Covid-19 Rapid Antigen Market Dynamics
8.1 Covid-19 Rapid Antigen Industry Trends
8.2 Covid-19 Rapid Antigen Market Drivers
8.3 Covid-19 Rapid Antigen Market Challenges
8.4 Covid-19 Rapid Antigen Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Covid-19 Rapid Antigen Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Covid-19 Rapid Antigen Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Covid-19 Rapid Antigen Market Competitive Situation by Manufacturers in 2023
Table 4. Global Covid-19 Rapid Antigen Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Covid-19 Rapid Antigen Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Covid-19 Rapid Antigen Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Covid-19 Rapid Antigen Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Covid-19 Rapid Antigen Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Covid-19 Rapid Antigen, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Covid-19 Rapid Antigen, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Covid-19 Rapid Antigen, Product Type & Application
Table 12. Global Key Manufacturers of Covid-19 Rapid Antigen, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Covid-19 Rapid Antigen by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Rapid Antigen as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Covid-19 Rapid Antigen Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Covid-19 Rapid Antigen Sales by Region (2019-2024) & (K Units)
Table 18. Global Covid-19 Rapid Antigen Sales Market Share by Region (2019-2024)
Table 19. Global Covid-19 Rapid Antigen Sales by Region (2025-2030) & (K Units)
Table 20. Global Covid-19 Rapid Antigen Sales Market Share by Region (2025-2030)
Table 21. Global Covid-19 Rapid Antigen Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Covid-19 Rapid Antigen Revenue Market Share by Region (2019-2024)
Table 23. Global Covid-19 Rapid Antigen Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Covid-19 Rapid Antigen Revenue Market Share by Region (2025-2030)
Table 25. North America Covid-19 Rapid Antigen Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Covid-19 Rapid Antigen Sales by Country (2019-2024) & (K Units)
Table 27. North America Covid-19 Rapid Antigen Sales by Country (2025-2030) & (K Units)
Table 28. North America Covid-19 Rapid Antigen Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Covid-19 Rapid Antigen Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Covid-19 Rapid Antigen Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Covid-19 Rapid Antigen Sales by Country (2019-2024) & (K Units)
Table 32. Europe Covid-19 Rapid Antigen Sales by Country (2025-2030) & (K Units)
Table 33. Europe Covid-19 Rapid Antigen Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Covid-19 Rapid Antigen Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Covid-19 Rapid Antigen Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Covid-19 Rapid Antigen Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Covid-19 Rapid Antigen Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Covid-19 Rapid Antigen Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Covid-19 Rapid Antigen Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Covid-19 Rapid Antigen Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Covid-19 Rapid Antigen Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Covid-19 Rapid Antigen Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Covid-19 Rapid Antigen Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Covid-19 Rapid Antigen Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Covid-19 Rapid Antigen Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Covid-19 Rapid Antigen Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Covid-19 Rapid Antigen Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Covid-19 Rapid Antigen Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Covid-19 Rapid Antigen Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Covid-19 Rapid Antigen Sales (K Units) by Type (2019-2024)
Table 51. Global Covid-19 Rapid Antigen Sales (K Units) by Type (2025-2030)
Table 52. Global Covid-19 Rapid Antigen Sales Market Share by Type (2019-2024)
Table 53. Global Covid-19 Rapid Antigen Sales Market Share by Type (2025-2030)
Table 54. Global Covid-19 Rapid Antigen Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Covid-19 Rapid Antigen Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Covid-19 Rapid Antigen Revenue Market Share by Type (2019-2024)
Table 57. Global Covid-19 Rapid Antigen Revenue Market Share by Type (2025-2030)
Table 58. Global Covid-19 Rapid Antigen Price (US$/Unit) by Type (2019-2024)
Table 59. Global Covid-19 Rapid Antigen Price (US$/Unit) by Type (2025-2030)
Table 60. Global Covid-19 Rapid Antigen Sales (K Units) by Application (2019-2024)
Table 61. Global Covid-19 Rapid Antigen Sales (K Units) by Application (2025-2030)
Table 62. Global Covid-19 Rapid Antigen Sales Market Share by Application (2019-2024)
Table 63. Global Covid-19 Rapid Antigen Sales Market Share by Application (2025-2030)
Table 64. Global Covid-19 Rapid Antigen Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Covid-19 Rapid Antigen Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Covid-19 Rapid Antigen Revenue Market Share by Application (2019-2024)
Table 67. Global Covid-19 Rapid Antigen Revenue Market Share by Application (2025-2030)
Table 68. Global Covid-19 Rapid Antigen Price (US$/Unit) by Application (2019-2024)
Table 69. Global Covid-19 Rapid Antigen Price (US$/Unit) by Application (2025-2030)
Table 70. Abbott Corporation Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Abbott Covid-19 Rapid Antigen Product
Table 74. Abbott Recent Developments/Updates
Table 75. Access Bio Corporation Information
Table 76. Access Bio Description and Business Overview
Table 77. Access Bio Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Access Bio Covid-19 Rapid Antigen Product
Table 79. Access Bio Recent Developments/Updates
Table 80. BD Corporation Information
Table 81. BD Description and Business Overview
Table 82. BD Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. BD Covid-19 Rapid Antigen Product
Table 84. BD Recent Developments/Updates
Table 85. Quidel Corporation Information
Table 86. Quidel Description and Business Overview
Table 87. Quidel Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Quidel Covid-19 Rapid Antigen Product
Table 89. Quidel Recent Developments/Updates
Table 90. Fujirebio Corporation Information
Table 91. Fujirebio Description and Business Overview
Table 92. Fujirebio Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Fujirebio Covid-19 Rapid Antigen Product
Table 94. Fujirebio Recent Developments/Updates
Table 95. Ellume Corporation Information
Table 96. Ellume Description and Business Overview
Table 97. Ellume Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Ellume Covid-19 Rapid Antigen Product
Table 99. Ellume Recent Developments/Updates
Table 100. OraSure Technologies Corporation Information
Table 101. OraSure Technologies Description and Business Overview
Table 102. OraSure Technologies Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. OraSure Technologies Covid-19 Rapid Antigen Product
Table 104. OraSure Technologies Recent Developments/Updates
Table 105. Clip Health Corporation Information
Table 106. Clip Health Description and Business Overview
Table 107. Clip Health Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Clip Health Covid-19 Rapid Antigen Product
Table 109. Clip Health Recent Developments/Updates
Table 110. Celltrion Healthcare Corporation Information
Table 111. Celltrion Healthcare Description and Business Overview
Table 112. Celltrion Healthcare Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Celltrion Healthcare Covid-19 Rapid Antigen Product
Table 114. Celltrion Healthcare Recent Developments/Updates
Table 115. Salofa Oy Corporation Information
Table 116. Salofa Oy Description and Business Overview
Table 117. Salofa Oy Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Salofa Oy Covid-19 Rapid Antigen Product
Table 119. Salofa Oy Recent Developments/Updates
Table 120. iHealth Labs Corporation Information
Table 121. iHealth Labs Description and Business Overview
Table 122. iHealth Labs Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. iHealth Labs Covid-19 Rapid Antigen Product
Table 124. iHealth Labs Recent Developments/Updates
Table 125. Novegent Corporation Information
Table 126. Novegent Description and Business Overview
Table 127. Novegent Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Novegent Covid-19 Rapid Antigen Product
Table 129. Novegent Recent Developments/Updates
Table 130. Hangzhou Alltest Biotech Corporation Information
Table 131. Hangzhou Alltest Biotech Description and Business Overview
Table 132. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product
Table 134. Hangzhou Alltest Biotech Recent Developments/Updates
Table 135. Guangzhou Decheng Biotechnology Corporation Information
Table 136. Guangzhou Decheng Biotechnology Description and Business Overview
Table 137. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product
Table 139. Guangzhou Decheng Biotechnology Recent Developments/Updates
Table 140. SD Biosensor Corporation Information
Table 141. SD Biosensor Description and Business Overview
Table 142. SD Biosensor Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. SD Biosensor Covid-19 Rapid Antigen Product
Table 144. SD Biosensor Recent Developments/Updates
Table 145. MP Biomedical Corporation Information
Table 146. MP Biomedical Description and Business Overview
Table 147. MP Biomedical Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. MP Biomedical Covid-19 Rapid Antigen Product
Table 149. MP Biomedical Recent Developments/Updates
Table 150. Jiangsu Well Biotech Corporation Information
Table 151. Jiangsu Well Biotech Description and Business Overview
Table 152. Jiangsu Well Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Jiangsu Well Biotech Covid-19 Rapid Antigen Product
Table 154. Jiangsu Well Biotech Recent Developments/Updates
Table 155. CTK Biotech Corporation Information
Table 156. CTK Biotech Description and Business Overview
Table 157. CTK Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. CTK Biotech Covid-19 Rapid Antigen Product
Table 159. CTK Biotech Recent Developments/Updates
Table 160. Hangzhou Laihe Biotech Corporation Information
Table 161. Hangzhou Laihe Biotech Description and Business Overview
Table 162. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product
Table 164. Hangzhou Laihe Biotech Recent Developments/Updates
Table 165. Innovation Scientific Corporation Information
Table 166. Innovation Scientific Description and Business Overview
Table 167. Innovation Scientific Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Innovation Scientific Covid-19 Rapid Antigen Product
Table 169. Innovation Scientific Recent Developments/Updates
Table 170. Biohit Healthcare Corporation Information
Table 171. Biohit Healthcare Description and Business Overview
Table 172. Biohit Healthcare Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 173. Biohit Healthcare Covid-19 Rapid Antigen Product
Table 174. Biohit Healthcare Recent Developments/Updates
Table 175. ACON Biotech Corporation Information
Table 176. ACON Biotech Description and Business Overview
Table 177. ACON Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 178. ACON Biotech Covid-19 Rapid Antigen Product
Table 179. ACON Biotech Recent Developments/Updates
Table 180. Assure Tech Corporation Information
Table 181. Assure Tech Description and Business Overview
Table 182. Assure Tech Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 183. Assure Tech Covid-19 Rapid Antigen Product
Table 184. Assure Tech Recent Developments/Updates
Table 185. Hangzhou Clongene Biotech Corporation Information
Table 186. Hangzhou Clongene Biotech Description and Business Overview
Table 187. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 188. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product
Table 189. Hangzhou Clongene Biotech Recent Developments/Updates
Table 190. Hangzhou Testsea Biotechnology Corporation Information
Table 191. Hangzhou Testsea Biotechnology Description and Business Overview
Table 192. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 193. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product
Table 194. Hangzhou Testsea Biotechnology Recent Developments/Updates
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Covid-19 Rapid Antigen Distributors List
Table 198. Covid-19 Rapid Antigen Customers List
Table 199. Covid-19 Rapid Antigen Market Trends
Table 200. Covid-19 Rapid Antigen Market Drivers
Table 201. Covid-19 Rapid Antigen Market Challenges
Table 202. Covid-19 Rapid Antigen Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Covid-19 Rapid Antigen
Figure 2. Global Covid-19 Rapid Antigen Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Covid-19 Rapid Antigen Market Share by Type in 2023 & 2030
Figure 4. Nasal Swab Product Picture
Figure 5. Oral Fluid/Saliva Product Picture
Figure 6. Global Covid-19 Rapid Antigen Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Covid-19 Rapid Antigen Market Share by Application in 2023 & 2030
Figure 8. Hospitals
Figure 9. Scientific Research
Figure 10. Global Covid-19 Rapid Antigen Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Covid-19 Rapid Antigen Market Size (2019-2030) & (US$ Million)
Figure 12. Global Covid-19 Rapid Antigen Sales (2019-2030) & (K Units)
Figure 13. Global Covid-19 Rapid Antigen Average Price (US$/Unit) & (2019-2030)
Figure 14. Covid-19 Rapid Antigen Report Years Considered
Figure 15. Covid-19 Rapid Antigen Sales Share by Manufacturers in 2023
Figure 16. Global Covid-19 Rapid Antigen Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Covid-19 Rapid Antigen Players: Market Share by Revenue in 2023
Figure 18. Covid-19 Rapid Antigen Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Covid-19 Rapid Antigen Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Covid-19 Rapid Antigen Sales Market Share by Country (2019-2030)
Figure 21. North America Covid-19 Rapid Antigen Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Covid-19 Rapid Antigen Sales Market Share by Country (2019-2030)
Figure 25. Europe Covid-19 Rapid Antigen Revenue Market Share by Country (2019-2030)
Figure 26. Germany Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Covid-19 Rapid Antigen Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Covid-19 Rapid Antigen Revenue Market Share by Region (2019-2030)
Figure 33. China Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Covid-19 Rapid Antigen Sales Market Share by Country (2019-2030)
Figure 44. Latin America Covid-19 Rapid Antigen Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Covid-19 Rapid Antigen Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Covid-19 Rapid Antigen Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.A.E Covid-19 Rapid Antigen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Covid-19 Rapid Antigen by Type (2019-2030)
Figure 54. Global Revenue Market Share of Covid-19 Rapid Antigen by Type (2019-2030)
Figure 55. Global Covid-19 Rapid Antigen Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Covid-19 Rapid Antigen by Application (2019-2030)
Figure 57. Global Revenue Market Share of Covid-19 Rapid Antigen by Application (2019-2030)
Figure 58. Global Covid-19 Rapid Antigen Price (US$/Unit) by Application (2019-2030)
Figure 59. Covid-19 Rapid Antigen Value Chain
Figure 60. Covid-19 Rapid Antigen Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
